Genetic Testing for Male Infertility: Karyotype, Y Microdeletions, and CFTR

If you’ve landed on “genetic testing” in the male infertility world, you’re not alone—and you’re not automatically in worst-case territory. Most couples start with a semen analysis and basic hormone...

If you’ve landed on “genetic testing” in the male infertility world, you’re not alone—and you’re not automatically in worst-case territory. Most couples start with a semen analysis and basic hormone labs, and only then (based on a few specific patterns) a clinician may recommend genetic tests to check if there’s an underlying, fixable-or-at-least-actionable genetic cause.

Think of genetic testing as a map. It doesn’t tell you everything about fertility, but in the right situation it can explain why sperm counts are very low or absent, forecast chances of finding sperm with a procedure, and help you avoid passing on certain conditions to a child.

Educational only; not medical advice.

Quick takeaways

Genetic tests are usually ordered when sperm count is very low (severe oligospermia) or zero (azoospermia), or when there’s a suggestion of blocked sperm delivery.
The “big three” for male infertility workups are: karyotype (chromosome count/structure), Y chromosome microdeletion testing (missing chunks of the Y that affect sperm production), and CFTR testing (linked to congenital absence of the vas deferens and cystic fibrosis carrier status).
These tests don’t diagnose “fertility” in a general sense—they look for specific genetic explanations that can change counseling and next steps.
Results often affect: likely success of sperm retrieval (e.g., micro-TESE), whether IVF/ICSI is recommended, and whether partner genetic testing and embryo testing (PGT) should be discussed.
A normal genetic panel does not rule out infertility. It just means the common high-yield genetic causes weren’t found.

Why genetics comes up in a male infertility workup

Most male infertility isn’t caused by a single “bad gene.” It’s a mix of hormones, anatomy, health, exposures, age, and plain biology. But genetics becomes especially relevant when the semen analysis shows something extreme or unusual—because that pattern increases the chance that sperm production or transport is being limited by a genetic factor.

Clinicians typically consider genetic testing when any of these show up:

Azoospermia (no sperm seen in the ejaculate) on at least two semen analyses.
Severe oligospermia (very low sperm concentration), often discussed as <5 million/mL—or particularly <1 million/mL—depending on the guideline and context.
Suspected obstruction (sperm production may be normal but the “pipes” are blocked), especially when vas deferens are absent on exam or semen volume is low with acidic pH.
Missing/abnormal puberty development, very small testes, or high FSH suggesting primary testicular failure.
Recurrent pregnancy loss or other family history flags that make chromosome testing relevant.

“Genetic testing isn’t about blame—it’s about clarity. When sperm counts are extremely low, it’s one of the fastest ways to understand what we’re dealing with and what your best options are.”

The three most common genetic tests (and what they’re looking for)

Here’s the high-level view before we go deeper: karyotype looks at the whole chromosome set, Y microdeletion testing looks for missing regions on the Y chromosome that are important for sperm production, and CFTR testing looks for variants linked to congenital absence of the vas deferens (a classic cause of obstructive azoospermia) and cystic fibrosis carrier status.

Test	What it measures	What it can suggest	What to do next (typical)
Karyotype	Number and structure of chromosomes (e.g., 46,XY vs 47,XXY; balanced translocations)	Klinefelter syndrome, translocations, inversions; higher risk of miscarriage/aneuploidy depending on finding	Genetic counseling; targeted fertility planning; consider sperm retrieval options; discuss IVF/ICSI and sometimes PGT
Y chromosome microdeletion	Missing micro-regions on Y chromosome (AZFa, AZFb, AZFc)	Impaired sperm production; predicts likelihood of sperm in ejaculate or from surgical retrieval	Counsel on sperm retrieval chances; if sperm found, discuss inheritance to male offspring via ICSI
CFTR	Variants in the CFTR gene (cystic fibrosis-related)	Congenital bilateral absence of vas deferens (CBAVD) causing obstruction; carrier status implications	Test partner for CFTR; genetic counseling; consider sperm retrieval + IVF/ICSI; assess kidneys/duct anatomy when indicated

Before genetic tests: the “setup” your clinician usually confirms

Genetic testing makes the most sense when it’s paired with the basics—because the pattern of findings is what makes results meaningful.

1) Repeat semen analysis (yes, repeat)

Semen parameters bounce around. Illness, fever, stress, abstinence window, collection issues, and lab variability all matter. For big decisions like genetic testing or surgery, most clinicians want at least two properly collected semen analyses (often separated by a few weeks). If azoospermia is suspected, the lab may also centrifuge the sample and look for rare sperm in the pellet.

2) Hormone labs

FSH, LH, total testosterone (and sometimes prolactin and estradiol) help sort “production” problems from “signal” problems. A classic pattern that raises the likelihood of a production issue is high FSH with small testes and very low/absent sperm—this is one reason karyotype and Y microdeletion testing come up.

3) Physical exam + history

A urologist is looking for clues like varicocele, testicular size, prior surgeries (hernia, undescended testes), infections, testosterone use, chemo/radiation exposure, and the presence or absence of the vas deferens.

Karyotype (chromosome analysis): what it is and when it’s ordered

A karyotype is the “big picture” chromosome test. Humans typically have 46 chromosomes. A typical male karyotype is 46,XY. This test checks whether you have the correct number of chromosomes and whether any are rearranged.

What happens (from your perspective)

It’s usually a blood draw. The lab grows cells, then analyzes chromosomes under a microscope. Turnaround time is commonly a couple weeks (sometimes longer).

What karyotype can find in male infertility

Klinefelter syndrome (47,XXY): One of the most common chromosome findings in men with non-obstructive azoospermia or severe oligospermia. It’s associated with primary testicular failure, smaller testes, and elevated FSH/LH. Some men can still have sperm in the testes that can be retrieved with micro-TESE and used with ICSI, depending on the situation.[2]
Balanced translocations: Pieces of chromosomes swap places but no genetic material is “lost” overall. The carrier is often healthy, but sperm/embryos can end up with unbalanced genetic material—this can show up as infertility, recurrent miscarriage, or failed IVF cycles.[3]
Other chromosome aneuploidies or structural changes: Less common, but can influence both fertility and pregnancy risks.

What results can mean (in plain English)

Normal karyotype (46,XY): Good news, but not “all clear.” Most infertility isn’t explained by karyotype. You may still have a treatable issue (varicocele, hormonal imbalance, obstruction) or an unexplained production problem.
47,XXY (Klinefelter): Explains the low/absent sperm production pattern. Next steps often include endocrine evaluation (testosterone symptoms matter), discussion of sperm retrieval options, and thoughtful timing if you’re considering micro-TESE/ICSI.
Balanced translocation: Often shifts the conversation toward genetic counseling and reproductive planning (sometimes including IVF with embryo genetic testing—PGT—depending on goals and history).

What karyotype can’t tell you

It won’t explain mild sperm issues most of the time.
It doesn’t measure sperm DNA fragmentation or “egg quality.”
It won’t identify most single-gene causes of infertility beyond big chromosome-level findings.

Y chromosome microdeletion testing: the “AZF regions” and why they matter

If sperm production is severely impaired, one key question is: does the Y chromosome have all the instructions it’s supposed to have for making sperm?

Y chromosome microdeletion testing looks for missing segments in regions called AZF (Azoospermia Factor): AZFa, AZFb, and AZFc. These microdeletions are too small to see on a standard karyotype. They’re found with molecular testing (usually a blood sample).

When clinicians order it

Non-obstructive azoospermia (NOA): no sperm in semen due to impaired production.
Severe oligospermia: especially when sperm counts are very low and hormones/exam suggest testicular production issues.[2]

How to think about the main result categories

Different labs may report slightly differently, but the clinical counseling usually centers on which AZF region is deleted.

Finding	What it often implies	Typical fertility implications	Common “next step” conversation
AZFa deletion	Severely impaired sperm production	Sperm retrieval success is very unlikely	Discuss alternatives (donor sperm, adoption) and ensure accurate diagnosis
AZFb deletion	Severely impaired maturation of sperm cells	Sperm retrieval success is usually very low	Counseling about low likelihood of finding sperm with micro-TESE
AZFc deletion (most common)	Variable sperm production	Some men have sperm in ejaculate or retrievable sperm; counts can decline over time	Consider sperm banking if sperm present; discuss micro-TESE/ICSI options
No deletion detected	Common Y deletions not found	Still may have NOA/severe oligospermia from other causes	Proceed with full evaluation/treatment plan based on obstruction vs production picture

A big counseling point: inheritance to sons

If you have a Y microdeletion and you conceive using ICSI with your sperm, a male child can inherit that deletion—because the Y chromosome is passed from father to son. That doesn’t mean “don’t do it.” It just means you deserve clear counseling about what it could mean for your future son’s fertility and what options exist (including sperm banking if he’s affected later in life, when appropriate).[2]

What Y microdeletion testing can’t tell you

It won’t explain obstructive azoospermia (where production is okay but transport is blocked).
It won’t identify non-Y genetic contributors (autosomal genes) to sperm production problems.
It doesn’t measure egg/sperm interaction or embryo development potential.

CFTR testing: the “blocked plumbing” genetic story (CBAVD)

CFTR is the gene associated with cystic fibrosis (CF). But in fertility clinics, CFTR comes up even in men who have never had lung problems and feel completely healthy—because certain CFTR variants are linked to congenital bilateral absence of the vas deferens (CBAVD).

The vas deferens is the tube that carries sperm from the epididymis to the ejaculate. If it’s absent on both sides, sperm usually can’t get into semen, leading to obstructive azoospermia.

When clinicians suspect CFTR-related obstruction

Azoospermia with exam findings suggesting obstruction (normal-sized testes, often normal FSH).
Vas deferens not palpable on one or both sides during physical exam.
Low semen volume and sometimes more acidic semen pH (patterns vary by lab and anatomy).
History clues: chronic sinus/lung issues (not always present), known CF in family, or prior fertility history suggesting normal sperm production but blocked delivery.

What the test looks for

CFTR testing checks for pathogenic variants. Some panels are broader than others. A common additional detail in male infertility is the 5T variant in intron 8 (often reported with related TG repeats), which can be associated with CBAVD in certain contexts. The exact interpretation depends on the full genotype and clinical picture, so this is one place where a genetic counselor shines.

Why CFTR results affect your partner, too

If you carry a CFTR variant associated with CBAVD, you may be a carrier for cystic fibrosis. If your partner is also a carrier of a CFTR pathogenic variant, there’s a risk of having a child affected with CF (or a CFTR-related disorder), which changes reproductive planning. That’s why partner testing and counseling often follow.[4]

What CFTR testing can’t tell you

It doesn’t diagnose cystic fibrosis on its own without the right clinical context.
It won’t explain non-obstructive azoospermia caused by testicular production failure.
It won’t guarantee that sperm retrieval will be easy—though in obstructive cases, sperm retrieval rates are generally good.

How these tests fit into an azoospermia workup (obstructive vs non-obstructive)

Azoospermia is a finding, not a diagnosis. The big fork in the road is:

Obstructive azoospermia (OA): sperm are being made, but can’t get out.
Non-obstructive azoospermia (NOA): sperm production is severely reduced or absent.

Genetic testing helps most when you’re in the NOA/severe oligospermia category (karyotype + Y microdeletions) or when the story screams “obstruction due to missing vas” (CFTR).

A simple way to connect the dots

Small testes + high FSH + azoospermia → think production problem → karyotype and Y microdeletions often ordered.[2]
Normal testes + normal FSH + azoospermia → think obstruction → CFTR testing if CBAVD suspected; also consider imaging/other evaluation.
Very low semen volume → consider collection factors, retrograde ejaculation, androgen deficiency, ejaculatory duct obstruction, or congenital duct differences—your clinician will sort this out with history, exam, and sometimes additional tests.

Common results scenarios (and what people usually do next)

Scenario 1: Severe oligospermia + normal karyotype + no Y microdeletions

This is common. It means the “big three” didn’t find an explanation. Next steps depend on the rest of your evaluation:

Look hard for treatable factors (varicocele, endocrine issues, medications/exposures, heat, anabolic steroids/testosterone use).
Discuss whether trying for natural conception is reasonable vs moving to IUI/IVF/ICSI based on total motile sperm count and partner factors.
Consider banking sperm if counts are very low and trending down.

Scenario 2: Azoospermia + CFTR variant(s) + absent vas deferens

This often points to CBAVD (obstruction). The key next steps usually include:

Partner CFTR testing and genetic counseling.[4]
Discuss sperm retrieval (from epididymis or testes) and IVF/ICSI.
Consider evaluation for associated anatomy differences (for example, some men with CBAVD can have kidney/urinary tract differences—your clinician will decide if imaging is appropriate).

Scenario 3: Non-obstructive azoospermia + Y microdeletion

The specific AZF region matters a lot for realistic expectations. Some deletions make sperm retrieval very unlikely; others (especially certain AZFc deletions) may still allow sperm retrieval or even rare sperm in the ejaculate. This is where you want a straight conversation about probability, timelines, and emotional bandwidth.

Scenario 4: Klinefelter (47,XXY)

You’re usually talking about NOA or extremely low counts. Fertility options can still exist—often via micro-TESE with ICSI in selected cases—but success varies. Hormone management can be tricky: you want to address low testosterone symptoms without accidentally worsening sperm production (exogenous testosterone can suppress the brain signals needed for sperm). This is individualized care—don’t DIY it.

What these tests mean for treatment (without assuming IVF is the only path)

Genetic results mainly influence three things:

Diagnosis and prognosis: why sperm are low/absent, and what the odds are of finding sperm with retrieval.
Safety and planning: risk of passing on a condition; whether partner testing or genetic counseling is important.
Efficiency: avoiding months of low-yield treatments when the genetics strongly predict they won’t work.

They don’t automatically force you into IVF. But they often clarify which route is most realistic.

Limitations and “gray zones” (so you don’t over-interpret)

A normal report doesn’t equal normal fertility. These tests target common, high-impact findings—not every genetic contributor.
Variants of uncertain significance (VUS) can happen on broader panels. A VUS is not a diagnosis; it’s a “we found something but we don’t know what it means yet.”
Lab panels differ. Especially with CFTR and expanded carrier screening, what’s tested and how it’s reported can vary.
Context rules. The same result can matter differently depending on semen analysis, hormones, exam findings, and partner factors.

What to ask your clinician (bring this to the visit)

“Based on my semen analysis pattern, are we thinking obstructive or non-obstructive azoospermia—and what supports that?”
“Which genetic tests do you recommend for me: karyotype, Y microdeletions, CFTR—and why?”
“If my karyotype/Y microdeletion results are abnormal, how does that change the chances of finding sperm with retrieval?”
“If CFTR is positive, should my partner be tested—and what are the possible implications for a baby?”
“Do you recommend genetic counseling now, or only if something comes back abnormal?”
“If we find sperm, do you recommend banking it? What would you do in your own family?”
“Are there any medications/supplements I’m taking (including testosterone) that could be worsening this?”
“If my tests are normal, what are the next highest-yield steps to explain my low sperm count?”

Tools that can help you stay sane while you track this

The genetics piece can feel heavy because it’s not something you can “willpower” your way through. What you can control is getting clean data, repeating key measurements at sensible intervals, and supporting sperm health while your clinician builds the full picture.

If you’re in a phase of monitoring changes over time (after illness, surgery, medication changes, or lifestyle shifts), an at-home sperm test option can be a practical way to track trends between clinic appointments.
If you and your clinician are working on overall sperm-support habits (sleep, heat exposure, nutrition, training load, supplements), some men like having a structured daily option such as SWMR Fertility for Men while you re-test on a consistent schedule.

Timing: when to retest and how to make results comparable

Genetic tests don’t need repeating (your chromosomes don’t change). But semen analysis and hormones often do—especially after you start treatment or make changes.

The 70–90 day concept (why everyone keeps saying “3 months”)

Sperm take time to develop. A change you make today—stopping testosterone, fixing a varicocele, treating an endocrine issue, recovering from a fever—usually won’t fully show up in semen for about 2–3 months. That’s why clinicians often recheck semen analysis around the 8–12 week mark, unless there’s a reason to check earlier.

How to retest so you can actually compare results

Use the same abstinence window each time (commonly 2–5 days; be consistent).
Use the same lab when possible (methodology differences are real).
Avoid testing within a few weeks of a febrile illness (fever can temporarily drop counts and motility).
Write down major confounders: new meds, supplements, hot tubs/saunas, drastic training changes, sleep deprivation, alcohol changes.
If azoospermia is the concern, ensure the lab does centrifugation/pellet check (ask directly).

FAQ

1) Do I need genetic testing if my semen analysis is only mildly abnormal?

Usually not. Genetic testing is most commonly ordered for azoospermia or very low sperm counts, or when there’s a strong suspicion of obstruction (like absent vas deferens).

2) What’s the difference between a karyotype and Y microdeletion testing?

Karyotype looks at the number and structure of chromosomes (big changes you can see under a microscope). Y microdeletion testing looks for tiny missing regions on the Y chromosome (too small for karyotype) that specifically affect sperm production.

3) If my karyotype is normal, does that mean my sperm DNA is normal?

No. A normal karyotype doesn’t evaluate sperm DNA fragmentation or embryo aneuploidy risk directly. It simply rules out major chromosome-number/structure issues detectable by karyotype.

4) If I have a Y chromosome microdeletion, can I still father a child?

Sometimes, yes—depending on which AZF region is affected and whether sperm can be found in the ejaculate or through surgical retrieval. If conception occurs via ICSI and you have a Y microdeletion, male offspring may inherit it.

5) What does CFTR have to do with male infertility if I don’t have cystic fibrosis?

Some CFTR variants are associated with congenital absence of the vas deferens (CBAVD), which blocks sperm transport and can cause obstructive azoospermia in otherwise healthy men.

6) If my CFTR test is positive, does my partner need testing?

Often, yes—because if both partners carry CFTR pathogenic variants, there can be a risk to the child (cystic fibrosis or related disorders). Your clinician or a genetic counselor can guide which test is appropriate.[4]

7) Can varicocele cause abnormal genetic tests?

No—varicocele doesn’t change your chromosomes. But varicocele can lower semen parameters, which is why clinicians try to separate “potentially correctable” causes from genetic production issues during the workup.

8) Can lifestyle changes fix a genetic cause of infertility?

Lifestyle changes can improve overall sperm health and may improve counts or motility, but they won’t replace missing genetic material (like certain Y deletions) or change a chromosome finding. They still matter—especially if you’re trying to optimize whatever sperm production you do have.

9) If I’m azoospermic, could sperm still be found later?

Yes, depending on the cause. In obstructive cases, sperm production may be normal and retrieval can be successful. In non-obstructive cases, sperm retrieval success varies and genetic results can help estimate the odds.

10) Should I do “expanded genetic carrier screening” instead of CFTR testing?

Expanded carrier screening can be helpful for family planning, but it’s not always a substitute for targeted CFTR evaluation when CBAVD/obstruction is suspected. Ask your clinician which approach answers the clinical question best, and consider genetic counseling for interpretation.

What to do next

Confirm the pattern: get (or repeat) at least one high-quality semen analysis, and confirm azoospermia with a second test if that’s the finding.
Get the basics: hormones (FSH, LH, testosterone ± prolactin/estradiol) and a focused exam with a male fertility urologist.
Ask which bucket you’re in: obstructive vs non-obstructive azoospermia (or severe oligospermia) and what supports that.
Do targeted genetics: karyotype + Y microdeletions for severe production issues; CFTR if obstruction/absent vas deferens is suspected.
Book genetic counseling if anything is abnormal (and often even if it’s borderline/complex), especially for CFTR results and chromosome rearrangements.
Create a fertility plan with timelines: whether that’s treatment (varicocele/hormonal), sperm banking, retrieval + IVF/ICSI, or alternative family-building options.
Standardize your tracking: if re-testing semen parameters, do it consistently (abstinence window, same lab, avoid post-fever testing) and think in 70–90 day blocks.

References

[1] World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th ed. WHO; 2021.
[2] American Urological Association (AUA) & American Society for Reproductive Medicine (ASRM). Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Updated guideline.
[3] Practice Committee of the American Society for Reproductive Medicine. Guidance on the clinical relevance of parental chromosomal abnormalities (including balanced translocations) in infertility and recurrent pregnancy loss.
[4] Practice guidance on congenital absence of the vas deferens and CFTR testing/counseling in male infertility (ASRM/ACMG-related recommendations and reviews).
[5] Krausz C, Riera-Escamilla A. Genetics of male infertility. Nature Reviews Urology. 2018;15(6):369-384.